{"id":"morphine-parecoxib","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1206690","moleculeType":"Small molecule","molecularWeight":"370.43"},"_fixedAt":"2026-03-30T18:09:45.179289","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Morphine binds to mu-opioid receptors in the central nervous system to reduce pain perception and emotional response to pain. Parecoxib selectively inhibits cyclooxygenase-2 (COX-2), reducing prostaglandin synthesis and inflammation at the site of injury. The combination provides multimodal analgesia for enhanced pain relief with potentially lower opioid requirements.","oneSentence":"This is a combination of morphine (an opioid mu-receptor agonist) and parecoxib (a selective COX-2 inhibitor) that provides analgesia through both opioid and anti-inflammatory pathways.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:55:52.570Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute postoperative pain"},{"name":"Moderate to severe pain requiring opioid analgesia"}]},"_fixedFields":["pubmed(1)"],"trialDetails":[{"nctId":"NCT07337135","phase":"NA","title":"Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery","status":"COMPLETED","sponsor":"Hospital dos Lusíadas","startDate":"2023-10-02","conditions":"Morbid Obesity, Postoperative Pain, Opioid Free Anesthesia","enrollment":60},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":"Intravenous Lidocaine, Laparoscopic Surgery, Post Operative Recovery","enrollment":182},{"nctId":"NCT06315920","phase":"PHASE3","title":"Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-05-01","conditions":"Sickle-Cell Disease with Crisis","enrollment":226},{"nctId":"NCT06721988","phase":"NA","title":"Effect of Preventive Analgesia with Oxycodone and Parecoxib Sodium on the Chronification of Acute Post-operative Pain","status":"NOT_YET_RECRUITING","sponsor":"Ailin Luo","startDate":"2025-01-01","conditions":"Oxycodone, Chronic Pain, Postoperative","enrollment":1316},{"nctId":"NCT04920019","phase":"NA","title":"Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2020-10-22","conditions":"Hepatoma, Pancreas Cancer","enrollment":140},{"nctId":"NCT05442411","phase":"PHASE1","title":"Regional Scalp Block Versus IV Parecoxib for Post-operative Cranioplasty Surgery Pain: A Comparison of Pain Score.","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2021-03-09","conditions":"Postoperative Pain","enrollment":58},{"nctId":"NCT04847024","phase":"NA","title":"Parecoxib vs. Dexketoprofen for the Management of Pain After Cesarean Section.","status":"COMPLETED","sponsor":"Saint Thomas Hospital, Panama","startDate":"2019-07-01","conditions":"Caesarean Section; Pain","enrollment":380},{"nctId":"NCT04314505","phase":"PHASE4","title":"Opioid-Sparing Protocol Comparing With Opioid-based Protocol After Bilateral Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2020-03-20","conditions":"Knee Replacement, Postoperative Pain, Opioid Use","enrollment":56},{"nctId":"NCT02749409","phase":"PHASE3","title":"Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture","status":"TERMINATED","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-08-08","conditions":"Parecoxib, Rib Fractures","enrollment":17},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Pain, Inflammation","enrollment":246},{"nctId":"NCT02272660","phase":"PHASE4","title":"Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-10","conditions":"Pain, Postoperative","enrollment":74},{"nctId":"NCT01526525","phase":"PHASE4","title":"Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy","status":"COMPLETED","sponsor":"G.Gennimatas General Hospital","startDate":"2009-07","conditions":"Pain, Postoperative","enrollment":70},{"nctId":"NCT00455117","phase":"PHASE4","title":"Effect of Parecoxib on Post-craniotomy Pain","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2006-09","conditions":"Anaesthesia","enrollment":130},{"nctId":"NCT01566669","phase":"NA","title":"Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery","status":"COMPLETED","sponsor":"Liu Weifeng","startDate":"2009-06","conditions":"Benign Female Reproductive System Neoplasm","enrollment":294},{"nctId":"NCT01541137","phase":"NA","title":"NSAIDs With Morphine-PCA Compared to Epidural Analgesia in Thoracotomy Pain","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2004-03","conditions":"Postoperative Pain","enrollment":30},{"nctId":"NCT00346268","phase":"PHASE4","title":"Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy","status":"TERMINATED","sponsor":"Pfizer","startDate":"2006-12","conditions":"Pain, Postoperative","enrollment":105},{"nctId":"NCT00143169","phase":"PHASE3","title":"Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2004-09","conditions":"Pain, Postoperative","enrollment":220}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"recentPublications":[{"date":"2005 Sep","pmid":"16102800","title":"Analgesic synergism between intrathecal morphine and cyclooxygenase-2 inhibitors in mice.","journal":"Pharmacology, biochemistry, and behavior"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Morphine, Parecoxib","genericName":"Morphine, Parecoxib","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination of morphine (an opioid mu-receptor agonist) and parecoxib (a selective COX-2 inhibitor) that provides analgesia through both opioid and anti-inflammatory pathways. Used for Acute postoperative pain, Moderate to severe pain requiring opioid analgesia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}